LIPID SCIENCES INC/

LIPID SCIENCES INC/ insiders are currently net buyers of LIPD stock, showing bullish sentiment over the past 90 days. Executives have purchased $4.0M while selling $174.1K, resulting in a positive net flow of $3.8M. This buying activity represents 96% of total transaction volume.

LIPID SCIENCES INC/ has 8 active insiders who have filed SEC Form 4 transactions in the past 90 days. William A. Pope (Executive) leads with 1 transactions totaling $3.4M. Bosko Djordjevic (Executive) follows with 4 transactions worth $241.8K. Open-market purchases require insiders to invest their own capital, demonstrating genuine conviction.

The Insider Alignment Score measures the ratio of buying to selling activity on a 0-100 scale. LIPID SCIENCES INC/'s current score of 96/100 indicates bullish insider sentiment. Scores above 60 suggest insiders are accumulating shares faster than selling, reflecting $4.0M in purchases versus $174.1K in sales.

The most recent insider transaction occurred on May 20, 2008, when Djordjevic Bosko (Executive) acquired 60,000 shares at $0.48 per share for $28.8K. This appears to be a discretionary trade.

Based on SEC Form 4 filings from the past 90 days, LIPD insider trading sentiment is currently bullish with an Alignment Score of 96/100. The net insider flow of $3.8M reflects accumulation, with 96% of volume being purchases.

SEC Form 4 is the primary disclosure mechanism for insider trading at publicly traded companies like LIPID SCIENCES INC/. Corporate insiders must file within two business days of any transaction, making it one of the most timely sources of executive sentiment. At LIPD, we track all Form 4 filings—currently showing 34 transactions from 8 insiders over 90 days.

A 10b5-1 plan allows LIPID SCIENCES INC/ executives to pre-schedule stock sales when they don't possess material non-public information. At LIPD, approximately 0% of recent transactions are 10b5-1 trades. Most trading activity at LIPD appears discretionary, making insider signals more meaningful.

You can monitor LIPID SCIENCES INC/ (LIPD) insider trading activity on this page, which updates within hours of new SEC Form 4 filings. We track all 8 active insiders and provide real-time transaction feeds, the Alignment Score, 10b5-1 vs. discretionary breakdowns, and direct links to SEC EDGAR filings.

Our Alignment Score measures the ratio of insider buying to selling on a scale of 0-100. A score above 70 indicates strong bullish sentiment, while below 30 suggests bearish activity. LIPID SCIENCES INC/'s current score of 96/100 indicates strong bullish sentiment with executives accumulating shares. This is calculated from $4.0M in purchases versus $174.1K in sales over 90 days, resulting in a net flow of $3.8M.

SEC Form 4 filings are mandatory reports that LIPID SCIENCES INC/ insiders must submit within 2 business days. Each filing includes the insider's name, relationship, transaction type, shares, and price. Transaction codes: P (purchase), S (sale), A (award), M (option exercise), G (gift). At LIPD, the most common type is "S" with 19 occurrences. The most recent Form 4 was filed on May 20, 2008 by Djordjevic Bosko.

Rule 10b5-1 allows corporate insiders to establish pre-scheduled trading plans when they don't possess material non-public information. At LIPID SCIENCES INC/, approximately 0% of recent transactions are executed under 10b5-1 plans, while 100% appear to be discretionary trades. The low percentage means most insider activity at LIPD represents discretionary decisions with more informational value.